Back to Search
JOHN BOGGESS, MD
MD
Gynecologic Oncology Physician
NPI: 1952499345IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
9501179(NC)
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy.
PMID 18928974·Am J Obstet Gynecol·2008
4-observational
A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
PMID 18928973·Am J Obstet Gynecol·2008
4-observational
Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.
PMID 16690106·Gynecol Oncol·2006
8-other
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
PMID 19656774·Hum Mol Genet·2009
4-observational
Emergence of robotic assisted surgery in gynecologic oncology: American perspective.
PMID 19573702·Gynecol Oncol·2009
6-review
Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
PMID 19484784·Cancer·2009
8-other
Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.
PMID 19088370·Reprod Sci·2008
4-observational
Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system.
PMID 18771796·Gynecol Oncol·2008
8-other
What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
PMID 18694588·Gynecol Oncol·2008
8-other
A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study.
PMID 18349277·Cancer Epidemiol Biomarkers Prev·2008
4-observational
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.
PMID 17906207·J Clin Oncol·2007
3-trial
Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
PMID 17275888·Gynecol Oncol·2007
8-other
The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.
PMID 16380156·Gynecol Oncol·2006
8-other
Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.
PMID 16249016·Gynecol Oncol·2006
8-other
EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.
PMID 16157366·Gynecol Oncol·2006
8-other
The use of non-nutritive sucking to decrease the physiologic pain response during neonatal circumcision: a randomized controlled trial.
PMID 16098887·Am J Obstet Gynecol·2005
3-trial
Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up.
PMID 15913741·Gynecol Oncol·2005
8-other
Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
PMID 15452833·Cancer·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-4996
Quick Facts
- NPI
- 1952499345
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile